[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603087":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":22,"locations":28,"responsibleParty":75,"collaborators":78,"id":86,"slug":10,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":10,"eligibilityCriteria":91,"healthyVolunteers":87,"sex":92,"minAge":93,"maxAge":10,"enrollmentInfo":94,"targetDuration":10,"studyType":97,"phases":10,"briefSummary":98,"conditions":99,"keywords":104,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"University of Erlangen-Nürnberg Medical School","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Primary brachytherapy",null,"Patients receiving sole primary brachytherapy (either LDR-BT or HDR-BT) for low or low intermediate risk prostate cancer",{"label":13,"type":10,"description":14,"interventionNames":10},"Salvage brachytherapy","Patients receiving sole brachytherapy (either PDR-BT or HDR-BT) for locally recurrent prostate cancer after prior irradiation with prostate in situ",[16,20],{"name":17,"affiliation":18,"role":19},"Claudia Schweizer, MD","Strahlenklinik Universitätsklinikum Erlangen","PRINCIPAL_INVESTIGATOR",{"name":21,"affiliation":18,"role":19},"Anna-Jasmina Donaubauer, Dr. rer. nat.",[23,27],{"name":17,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","+49 9131 85 33968","claudia.schweizer@uk-erlangen.de",{"name":21,"role":24,"phone":10,"phoneExt":10,"email":10},[29,47,62],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Klinik für Strahlentherapie","NOT_YET_RECRUITING","Augsburg","Bavaria","86156","Germany",{"type":37,"coordinates":38},"Point",[39,40],10.89851,48.37154,{"lat":40,"lon":39},[43],{"name":44,"role":24,"phone":45,"phoneExt":10,"email":46},"Klinik für Strahlentherapie Augsburg","+49 821 400-2080","strahlenklinik@uk-augsburg.de",{"facility":48,"status":49,"city":50,"state":33,"zip":51,"country":35,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Strahlenklinik Erlangen","RECRUITING","Erlangen","91054",{"type":37,"coordinates":53},[54,55],11.00783,49.59099,{"lat":55,"lon":54},[58],{"name":59,"role":24,"phone":60,"phoneExt":10,"email":61},"Strahlenklinik Erlangen Ambulanz","+4991318534080","sekretariat.strahlenklinik@uk-erlangen.de",{"facility":63,"status":31,"city":64,"state":33,"zip":65,"country":35,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Klinik und Poliklinik für Strahlentherapie und Radioonkologie","Munich","81377",{"type":37,"coordinates":67},[68,69],11.57549,48.13743,{"lat":69,"lon":68},[72],{"name":63,"role":24,"phone":73,"phoneExt":10,"email":74},"+49 (0)89 \u002F 4400 - 73770","strahl.onlinetermine@med.uni-muenchen.de",{"type":19,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Claudia Schweizer","Claudia Schweizer MD",[79,82,84],{"name":80,"class":81},"Bavarian Cancer Research Center (BZKF)","UNKNOWN",{"name":83,"class":6},"University Hospital Augsburg",{"name":85,"class":6},"Ludwig-Maximilians - University of Munich","100603087",false,"NCT07131956","Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy","Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy (ImmunBioProBrachy)","Inclusion Criteria Arm 1:\n\n* Primary treatment with I-125 seeds or HDR-BT\n* No previous treatment for prostate cancer\n* Age ≥ 18 years\n\nInclusion Criteria Arm 2:\n\n* HDR- or PDR-BT\n* No radiation therapy within three months before salvage treatment\n* Complete documentation available on previous treatment for prostate cancer\n* No history of prostatectomy\n* Age ≥ 18 years\n\nExclusion Criteria:\n\n* Pre-existent auto-immune disease\n* patients under bloodthinning medication\n* substance abuse","MALE","18 Years",{"count":95,"type":96},200,"ESTIMATED","OBSERVATIONAL","Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.",[100,101,102,103],"Prostate Cancer (Diagnosis)","Prostate Cancer Patients Who Have Brachytherapy Seed Implant","Prostate Cancer Patients Treated by Radiotherapy","Prostate Cancer Recurrent",[105,106,107],"Immune-profiling in prostate cancer patients","brachytherapy for prostate cancer","interstitial brachytherapy for prostate cancer","2025-11-17",{"date":110,"type":111},"2025-11-18","ACTUAL",{"date":113,"type":96},"2025-12",{"date":115,"type":96},"2028-07-31",{"name":5,"class":6},3]